+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fibrin"

From
Fibrin Sealants - Global Strategic Business Report - Product Thumbnail Image

Fibrin Sealants - Global Strategic Business Report

  • Report
  • March 2024
  • 92 Pages
  • Global
From
From
Hemophilia A - Pipeline Insight, 2024 - Product Thumbnail Image

Hemophilia A - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
From
From
From
From
Drug Overview: Pradaxa - Product Thumbnail Image

Drug Overview: Pradaxa

  • Report
  • March 2018
  • 34 Pages
  • Global
From
Loading Indicator

The Fibrin market is a segment of the Hematological Drugs market, which includes drugs used to treat blood-related diseases. Fibrin is a protein that helps the body form blood clots, and is used to treat conditions such as deep vein thrombosis, pulmonary embolism, and bleeding disorders. Fibrin is also used in surgical procedures to help control bleeding. Fibrin is available in a variety of forms, including topical creams, injectable solutions, and topical gels. It is also available in combination with other drugs, such as anticoagulants and thrombolytics. The Fibrin market is highly competitive, with many companies offering products in different forms and combinations. Some of the major players in the market include Pfizer, Novo Nordisk, Sanofi, Bayer, and CSL Behring. Show Less Read more